Citation profile for Margherita Neri

Margherita Neri : Citation Profile

H index

i10 index

Citations

RESEARCH PRODUCTION:

Articles

Papers

RESEARCH ACTIVITY:

   5 years (2017 - 2022). See details.
   Cites by year: 1
   Journals where Margherita Neri has often published
   Relations with other researchers
   Recent citing documents: 0.    Total self citations: 2 (20 %)

MORE DETAILS IN:

EconPapers

ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pne341
   Updated: 2024-01-16    RAS profile: 2023-05-12
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Brassel, Simon (3)

Authors registered in RePEc who have co-authored more than one work in the last five years with Margherita Neri.

Is cited by:

Pertile, Paolo (1)

Shah, Koonal (1)

Graf von der Schulenburg, Johann (1)

LEVAGGI, ROSELLA (1)

Cites to:

Towse, Adrian (6)

Cole, Amanda (4)

Danzon, Patricia (4)

Kuhn, Michael (3)

Prettner, Klaus (3)

Lorgelly, Paula (2)

Zamora Talaya, Bernarda (2)

Newhouse, Joseph (2)

Hollingsworth, Bruce (2)

Pammolli, Fabio (1)

Amado, Carla (1)

Main data

Where Margherita Neri has published?

Journals with more than one article published	# docs
Applied Health Economics and Health Policy	2

Working Papers Series with more than one paper published	# docs
Briefing / Office of Health Economics	2

Recent works citing Margherita Neri (2024 and 2023)

Year	Title of citing document

Works by Margherita Neri:

Year	Title	Type	Cited
2017	Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help? In: Briefing. [Full Text][Citation analysis]	paper	0
2018	Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward In: Briefing. [Full Text][Citation analysis]	paper	4
2020	Realising the Broader Value of Vaccines in the UK In: Consulting Report. [Full Text][Citation analysis]	paper	0
2021	Realising The Broader Value of Vaccines in the UK: Ready for Prime Time? In: Consulting Report. [Full Text][Citation analysis]	paper	0
2021	Payment Models for Multi-Indication Therapies In: Consulting Report. [Full Text][Citation analysis]	paper	0
2021	The Value of Vaccines in Maintaining Health System Capacity in England In: Consulting Report. [Citation analysis]	paper	0
2018	R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C In: Research Paper. [Full Text][Citation analysis]	paper	3
2019	HTA and Payment Mechanisms for New Drugs to Tackle AMR In: Research Paper. [Full Text][Citation analysis]	paper	0
2020	THE BRAVE INITIATIVE. The BRAVE Narrative for Broad Recognition of Value in Vaccines Engagement. In: Research Paper. [Full Text][Citation analysis]	paper	0
2022	Approaches to Measure Efficiency in Primary Care: A Systematic Literature Review In: Applied Health Economics and Health Policy. [Full Text][Citation analysis]	article	1
2022	Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward In: Applied Health Economics and Health Policy. [Full Text][Citation analysis]	article	0